Current Management of Secondary Hyperparathyroidism: A Multicenter Observational Study (COSMOS)

Journal of Nephrology

Volumn 21, Issue 3, 2008, Pages 290-298

  Cannata Andía, Jorge B ^a   Fernández Martín, José Luis ^a   Zoccali, Carmine ^b   London, Gérard M ^c   Locastelli, Francesco ^d   Ketteler, Markus ^e   Ferreira, Anibal ^f   Covic, Adrian ^g   Floege, Jürgen ^h   Górriz, José Luis ⁱ   Rutkowski, Boleslaw ^j   Memmos, Dimitrios E ^k   Verbeelen, Dierik ^l   Tielemans, Christian ^m   Teplan, Vladimir ⁿ   Bos, Willem Jan ^o   Nagy, Judit ^p   Kramar, Reinhard ^q   Goldsmith, David J A ^r   Martin, Pierre Yves ^s   Wüthrich, Rudolf P ^t   Pavlovic, Drasko ^u   Benedik, Mihael ^v   more..

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^b CNR Consiglio Nazionale delle Ricerche   (Italy)

^c Manhes Hospital   (France)

^d A MANZONI HOSPITAL   (Italy)

^e III Medical Department   (Germany)

^f NOVA MEDICAL SCHOOL   (Portugal)

^g Hospital CI Parhon   (Romania)

^h RWTH AACHEN UNIVERSITY   (Germany)

ⁱ HOSPITAL UNIVERSITARIO DR PESET   (Spain)

^j MEDICAL UNIVERSITY OF GDANSK   (Poland)

^k Aristotle University of Thessaloniki   (Greece)

^l UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^m UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

ⁿ INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^o ST ANTONIUS HOSPITAL   (Netherlands)

^p UNIVERSITY OF PÉCS   (Hungary)

^q Klinikum Kreuzschwestern Wels   (Austria)

^r GUY S HOSPITAL   (United Kingdom)

^s GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^t UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^u SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

^v UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CALCIUM PHOSPHATE; HEMOGLOBIN; HUMAN ALBUMIN; PARATHYROID HORMONE; PHOSPHORUS; BIOLOGICAL MARKER;

ADULT; ARTICLE; BONE BIOPSY; BONE METABOLISM; BONE MINERAL; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CLINICAL PRACTICE; EUROPE; FEMALE; FRACTURE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HOSPITALIZATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PARATHYROIDECTOMY; PREDICTION; PREVALENCE; SECONDARY HYPERPARATHYROIDISM; BONE DENSITY; CLINICAL TRIAL; KIDNEY DISEASE; METABOLISM; METHODOLOGY; MULTICENTER STUDY; OBSERVATION; RENAL REPLACEMENT THERAPY;

BIOLOGICAL MARKERS; BONE DENSITY; HUMANS; HYPERPARATHYROIDISM, SECONDARY; KIDNEY DISEASES; MULTICENTER STUDIES AS TOPIC; OBSERVATION; RENAL DIALYSIS; RESEARCH DESIGN;

EID: 52049112830     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Block GA, Hulbert-Shearon TE, Levin NW, Port FK. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis. 1998;31:607-617.
2. Block GA, Port FK. Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management. Am J Kidney Dis. 2000;35:1226-1237.
3. Goodman WG, Goldin J, Kuizon BD, et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med. 2000;342:1478-1483.
4. Slatopolsky E, Delmez JA. Pathogenesis of secondary hyperparathyroidism. Nephrol Dial Transplant. 1996;11(suppl 3):130-135.
5. Brown EM, Gamba G, Riccardi D, et al. Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid. Nature. 1993;366:575-580.
6. Drueke TB. Parathyroid gland hyperplasia in uremia. Kidney Int. 2001;59:1182-1183.
7. Gorriz JL, Sancho A, Pallardo LM, et al. Longer pre-dialysis nephrological care is associated with improved long-term survival of dialysis patients: more facts. Nephrol Dial Transplant. 2002;17:1354-1355.
8. National Kidney Foundation. NFK-K/DOQI clinical practice guidelines for bone metabolism in chronic kidney disease. Am J Kidney Dis. 2003;42(suppl 4):S1-S201.
9. Locatelli F, Marcelli D, Conte F, et al. Cardiovascular disease in chronic renal failure: the challenge continues. Registro Lombardo Dialisi e Trapianto. Nephrol Dial Transplant. 2000;15(suppl 5):69-80.
10. Kestenbaum B, Seliger SL, Gillen DL, et al. Parathyroidectomy rates among United States dialysis patients: 1990-1999. Kidney Int. 2004;65:282-288.
11. Rubel JR, Milford EL. The relationship between serum calcium and phosphate levels and cardiac valvular procedures in the hemodialysis population. Am J Kidney Dis. 2003;41:411-421.
12. Eknoyan G, Levin A, Levin N. Bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003;42:1-201.
13. Cannata JB, Fernández-Martín JL, Díaz-Corte C; ROD Multicentre Study. Applying the K/DOQI guidelines cut-off levels to the dialysis population: how far are we from the target? J Am Soc Nephrol. 2003;14:474A.
14. Diaz Corte C, Rodriguez A, Naves ML, Fernandez Martin JL, Cannata JB; Centros Colaboradores del Estudio Multicentrico sobre Osteodistrofia Renal. Marcadores metabólicos óseos y uso de vitamina D en diálisis. Nefrologia. 2000;20:244-253.
15. Diaz-Corte C, Cannata-Andia JB. Management of secondary hyperparathyroidism: the gap between diagnosis and treatment. The Renal Osteodystrophy Multicenter Enquiry. Am J Med Sci. 2000;320:107-111.
16. Diaz-Corte C, Naves Diaz ML, Gomez Alonso C, Barreto S, Cannata Andia JB. Prevention, diagnosis and treatment of renal osteodystrophy in Spain: preliminary results from a multicentre enquiry. Nephrol Dial Transplant. 1998;13(suppl 3):51-56.
17. Goodkin DA, Mapes DL, Held PJ. The Dialysis Outcomes and Practice Patterns Study (DOPPS): how can we improve the care of hemodialysis patients? Semin Dial. 2001;14:157-159.
18. Walters B, Danese M, Kim J, Klassen P. Patient prevalence within proposed NKF-K/DOQI guidelines for bone metabolism and disease. J Am Soc Nephrol. 203;14:473A.